Migraine remains second among the world's causes of disability, and first among young women: findings from GBD2019
- PMID: 33267788
- PMCID: PMC7708887
- DOI: 10.1186/s10194-020-01208-0
Migraine remains second among the world's causes of disability, and first among young women: findings from GBD2019
Conflict of interest statement
All authors are Directors and Trustees of
Similar articles
-
The burden of disease among the global poor.Lancet. 1999 Aug 14;354(9178):586-9. doi: 10.1016/S0140-6736(99)02108-X. Lancet. 1999. PMID: 10470717
-
Migraine.Discov Med. 2004 Oct;4(23):270-6. Discov Med. 2004. PMID: 20704958
-
Predicting disability and quality of life in a community-based sample of women with migraine headache.Pain Manag Nurs. 2000 Dec;1(4):139-51. doi: 10.1053/jpmn.2000.19344. Pain Manag Nurs. 2000. PMID: 11709867
-
Migrainomics - identifying brain and genetic markers of migraine.Nat Rev Neurol. 2017 Dec;13(12):725-741. doi: 10.1038/nrneurol.2017.151. Epub 2017 Nov 17. Nat Rev Neurol. 2017. PMID: 29146952 Review.
-
Migraine.Lancet. 2004 Jan 31;363(9406):381-91. doi: 10.1016/S0140-6736(04)15440-8. Lancet. 2004. PMID: 15070571 Review.
Cited by
-
[Migraine and pregnancy : Gender-specific aspects and current knowledge].Nervenarzt. 2024 Apr;95(4):308-315. doi: 10.1007/s00115-024-01615-7. Epub 2024 Feb 6. Nervenarzt. 2024. PMID: 38321287 Review. German.
-
Effectiveness of Switching CGRP Monoclonal Antibodies in Non-Responder Patients in the UAE: A Retrospective Study.Neurol Int. 2024 Feb 18;16(1):274-288. doi: 10.3390/neurolint16010019. Neurol Int. 2024. PMID: 38392960 Free PMC article.
-
The history and rationale of the development of new drugs for migraine treatment.Arq Neuropsiquiatr. 2023 Dec;81(12):1084-1097. doi: 10.1055/s-0043-1777723. Epub 2023 Dec 29. Arq Neuropsiquiatr. 2023. PMID: 38157876 Free PMC article. Review.
-
Unravelling Migraine Stigma: A Comprehensive Review of Its Impact and Strategies for Change.J Clin Med. 2024 Sep 3;13(17):5222. doi: 10.3390/jcm13175222. J Clin Med. 2024. PMID: 39274435 Free PMC article. Review.
-
Efficacy and safety of atogepant, a small molecule CGRP receptor antagonist, for the preventive treatment of migraine: a systematic review and meta-analysis.J Headache Pain. 2024 Jul 19;25(1):116. doi: 10.1186/s10194-024-01822-2. J Headache Pain. 2024. PMID: 39030528 Free PMC article.
References
-
- Institute for Health Metrics and Evaluation (2020) At: https://mailchi.mp/healthdata/07022020-2871488?e=99a49e288b
-
- Institute for Health Metrics and Evaluation . GBD collaborator newsletter June–September 2020. Seattle, WA: IHME; 2020.
-
- Institute for Health Metrics and Evaluation (2020) At: http://www.healthdata.org/results/gbd_summaries/2019/headache-disorders-...
Publication types
LinkOut - more resources
Full Text Sources
Medical